Efficacy and safety evaluation based on time from completion of radiotherapy to randomization with durvalumab or placebo in pts from PACIFIC

Faivre-Finn C., Spigel D. R. , Senan S., Langer C. J. , Raben D., Perez B., ...More

43rd ESMO Congress (ESMO), Munich, Germany, 19 - 23 October 2018, vol.29, pp.488 identifier

  • Publication Type: Conference Paper / Summary Text
  • Volume: 29
  • City: Munich
  • Country: Germany
  • Page Numbers: pp.488